- •PROGRESS IN BRAIN RESEARCH
- •List of Contributors
- •Preface
- •Epidemiology of primary glaucoma: prevalence, incidence, and blinding effects
- •Introduction
- •Prevalence of glaucoma
- •PAC suspect
- •PACG
- •Incidence of glaucoma
- •Blinding effects of glaucoma
- •Abbreviations
- •Acknowledgment
- •References
- •Predictive models to estimate the risk of glaucoma development and progression
- •Risk assessment in ocular hypertension and glaucoma
- •Risk factors for glaucoma development
- •Intraocular pressure
- •Corneal thickness
- •Cup/disc ratio and pattern standard deviation
- •The need for predictive models
- •Predictive models for glaucoma development
- •Predictive models for glaucoma progression
- •Limitations of predictive models
- •References
- •Intraocular pressure and central corneal thickness
- •Main text
- •References
- •Angle-closure: risk factors, diagnosis and treatment
- •Introduction
- •Mechanism
- •Other causes of angle closure
- •Risk factors
- •Age and gender
- •Ethnicity
- •Ocular biometry
- •Genetics
- •Diagnosis
- •Acute primary angle closure
- •Angle assessment in angle closure
- •Gonioscopy technique
- •Ultrasound biomicroscopy (UBM)
- •Scanning peripheral anterior chamber depth analyzer (SPAC)
- •Management
- •Acute primary angle closure
- •Medical therapy
- •Argon laser peripheral iridoplasty (ALPI)
- •Laser peripheral iridotomy (PI)
- •Lens extraction
- •Monitoring for subsequent IOP rise in eyes with APAC
- •Fellow eye of APAC
- •Chronic primary angle-closure glaucoma (CACG)
- •Laser peripheral iridotomy
- •Laser iridoplasty
- •Medical therapy
- •Trabeculectomy
- •Lens extraction
- •Combined lens extraction and trabeculectomy surgery
- •Goniosynechialysis
- •Summary
- •List of abbreviations
- •References
- •Early diagnosis in glaucoma
- •Introduction
- •History and examination
- •Quantitative tests and the diagnostic process
- •Pretest probability
- •Test validity
- •Diagnostic test performance
- •Posttest probability
- •Combing test results
- •Selective tests of visual function
- •Early glaucoma diagnosis from quantitative test results
- •Progression to make a diagnosis
- •Conclusions
- •Abbreviations
- •References
- •Monitoring glaucoma progression
- •Introduction
- •Monitoring structural damage progression
- •Monitoring functional damage progression
- •Abbreviations
- •References
- •Standard automated perimetry and algorithms for monitoring glaucoma progression
- •Standard automated perimetry
- •Global indices
- •HFA: MD, SF, PSD, CPSD
- •Octopus indices: MD, SF, CLV
- •OCTOPUS seven-in-one report (Fig. 2)
- •SAP VF assessment: full-threshold strategy
- •SAP VF defects assessment: OHTS criteria
- •SAP VF defects assessment: AGIS criteria
- •SAP VF defects assessment: CIGTS
- •Fastpac
- •Swedish interactive threshold algorithm
- •SAP VF assessment: the glaucoma staging system
- •SAP: interocular asymmetries in OHTS
- •SAP, VF progression
- •SAP: the relationship to other functional and structural diagnostic tests in glaucoma
- •SAP, FDP-Matrix
- •SAP, SWAP, HPRP, FDT
- •SAP: the relationship between function and structure
- •SAP, confocal scanning laser ophthalmoscopy, SLP-VCC
- •SAP, optical coherence tomography
- •SAP and functional magnetic resonance imaging
- •References
- •Introduction
- •Retinal ganglion cells: anatomy and function
- •Is glaucoma damage selective for any subgroup of RGCs?
- •Segregation
- •Isolation
- •FDT: rationale and perimetric techniques
- •SWAP: rationale and perimetric techniques
- •FDT: clinical data
- •SWAP: clinical data
- •Clinical data comparing FDT and SWAP
- •Conclusions
- •References
- •Scanning laser polarimetry and confocal scanning laser ophthalmoscopy: technical notes on their use in glaucoma
- •The GDx scanning laser polarimeter
- •Serial analysis
- •Limits
- •The Heidelberg retinal tomograph
- •Limits
- •Conclusions
- •References
- •The role of OCT in glaucoma management
- •Introduction
- •How OCT works
- •How OCT is performed
- •Evaluation of RNFL thickness
- •Evaluation of optic disc
- •OCT in glaucoma management
- •New perspective
- •Abbreviations
- •References
- •Introduction
- •Technology
- •Visual stimulation
- •Reproducibility and habituation of RFonh
- •Retinal neural activity as assessed from the electroretinogram (ERG)
- •The Parvo (P)- and Magno (M)-cellular pathways
- •Physiology
- •Magnitude and time course of RFonh in humans
- •Varying the parameters of the stimulus on RFonh
- •Luminance versus chromatic modulation
- •Frequency
- •Effect of pattern stimulation
- •Neurovascular coupling in humans
- •Clinical application
- •RFonh in OHT and glaucoma patients
- •Discussion
- •FLDF and neurovascular coupling in humans
- •Comments on clinical application of FLDF in glaucoma
- •Conclusions and futures directions
- •Acknowledgements
- •References
- •Advances in neuroimaging of the visual pathways and their use in glaucoma
- •Introduction
- •Conventional MR imaging and the visual pathways
- •Diffusion MR imaging
- •Functional MR imaging
- •Proton MR spectroscopy
- •References
- •Primary open angle glaucoma: an overview on medical therapy
- •Introduction
- •When to treat
- •Whom to treat
- •Genetics
- •Race
- •Ocular and systemic abnormalities
- •Tonometry and pachymetry
- •How to treat
- •Beta-blockers
- •Prostaglandins
- •Alpha-agonists
- •Carbonic anhydrase inhibitors (CAIs)
- •Myotics
- •Fixed combinations
- •References
- •The treatment of normal-tension glaucoma
- •Introduction
- •Epidemiology
- •Clinical features
- •Optic disk
- •Central corneal thickness
- •Disease course
- •Risk factors
- •Intraocular pressure
- •Local vascular factors
- •Immune mechanisms
- •Differential diagnosis
- •Diagnostic evaluation
- •Therapy
- •IOP reduction
- •Systemic medications
- •Neuroprotection
- •Noncompliance
- •Genetics of NTG
- •Abbreviations
- •References
- •The management of exfoliative glaucoma
- •Introduction
- •Epidemiology
- •Ocular and systemic associations
- •Ocular associations
- •Systemic associations
- •Pathogenesis of exfoliation syndrome
- •Mechanisms of glaucoma development
- •Management
- •Medical therapy
- •Laser surgery
- •Operative surgery
- •Future treatment of exfoliation syndrome and exfoliative glaucoma
- •Treatment directed at exfoliation material
- •References
- •Laser therapies for glaucoma: new frontiers
- •Background
- •Laser iridotomy
- •Indications
- •Contraindications
- •Patient preparation
- •Technique
- •Nd:YAG laser iridectomy
- •Argon laser iridectomy
- •Complications
- •LASER trabeculoplasty
- •Treatment technique
- •Mechanism of action
- •Indications for treatment
- •Contraindications to treatment
- •Patient preparation and postoperative follow-up
- •Complications of the treatment
- •Selective laser trabeculoplasty
- •Results
- •LASER iridoplasty
- •Indications
- •Contraindications
- •Treatment technique
- •Complications
- •LASER cyclophotocoagulation
- •Introduction
- •Indications and contraindications
- •Patient preparation
- •Transpupillary cyclophotocoagulation
- •Endoscopic cyclophotocoagulation
- •Transscleral cyclophotocoagulation
- •Transscleral noncontact cyclophotocoagulation
- •Transscleral contact cyclophotocoagulation
- •Complications
- •Excimer laser trabeculotomy
- •References
- •Modulation of wound healing during and after glaucoma surgery
- •The process of wound healing
- •Using surgical and anatomical principles to modify therapy
- •Growth factors
- •Cellular proliferation and vascularization
- •Cell motility, matrix contraction and synthesis
- •Drug delivery
- •Future directions: total scarring control and tissue regeneration
- •Acknowledgments
- •References
- •Surgical alternative to trabeculectomy
- •Introduction
- •Deep sclerectomy
- •Viscocanalostomy
- •Conclusions
- •References
- •Modern aqueous shunt implantation: future challenges
- •Background
- •Current shunts and factors affecting their function
- •Shunt-related factors
- •Surface area
- •Plate material
- •Valved versus non-valved
- •Commercially available devices
- •Comparative studies
- •Patient and ocular factors
- •Severity of glaucoma damage
- •Tolerance of topical ocular hypotensive medications
- •Aqueous hyposecretion
- •Previous ocular surgery
- •Scleral thinning
- •Patient cooperation for and tolerance of potential slit-lamp interventions
- •Future challenges
- •Predictability
- •Cataract formation
- •The long-term effect on the cornea
- •References
- •Model systems for experimental studies: retinal ganglion cells in culture
- •Mixed RGCs in culture
- •Retinal explants
- •Glial cultures
- •RGC-5 cells
- •Differentiation of RGC-5 cells
- •RGC-5 cell neurites
- •Advantages and disadvantages of culture models
- •References
- •Rat models for glaucoma research
- •Rat models for glaucoma research
- •Use of animal models for POAG
- •Suitability of the rat for models of optic nerve damage in POAG
- •Methods for measuring IOP in rats
- •General considerations for measuring IOP in rats
- •Assessing optic nerve and retina damage
- •Experimental methods of producing elevated IOP
- •Laser treatment of limbal tissues
- •Episcleral vein cautery
- •Conclusions
- •Abbreviations
- •Acknowledgements
- •References
- •Mouse genetic models: an ideal system for understanding glaucomatous neurodegeneration and neuroprotection
- •Introduction
- •The mouse as a model system
- •Mice are suitable models for studying IOP elevation in glaucoma
- •Tools for glaucoma research
- •Accurate IOP measurements are fundamental to the study of glaucoma
- •The future of IOP assessment
- •Assessment of RGC function
- •Mouse models of glaucoma
- •Primary open-angle glaucoma
- •MYOC
- •OPTN
- •Strategies for developing new models of POAG
- •Developmental glaucoma
- •Pigmentary glaucoma
- •Experimentally induced models of glaucoma
- •Mouse models to characterize processes involved in glaucomatous neurodegeneration
- •Similar patterns of glaucomatous damage occur in humans and mice
- •The lamina cribrosa is an important site of early glaucomatous damage
- •An insult occurs to the axons of RGCs within the lamina in glaucoma
- •What is the nature of the insult at the lamina?
- •Other changes occur in the retina in glaucoma
- •PERG and complement
- •Using mouse models to develop neuroprotective strategies
- •Somal protection
- •Axonal protection
- •Erythropoietin administration
- •Radiation-based treatment
- •References
- •Clinical trials in neuroprotection
- •Introduction
- •Methods of clinical studies
- •Issues in the design and conduct of clinical trials
- •Clinical trials of neuroprotection
- •Clinical trials of neuroprotection in ophthalmology
- •Endpoints
- •Neuroprotection and glaucoma
- •Conclusions
- •Abbreviations
- •References
- •Pathogenesis of ganglion ‘‘cell death’’ in glaucoma and neuroprotection: focus on ganglion cell axonal mitochondria
- •Introduction
- •Retinal ganglion cells and mitochondria
- •Possible causes for ganglion cell death in glaucoma
- •Mitochondrial functions and apoptosis
- •Mitochondrial function enhancement and the attenuation of ganglion cell death
- •Creatine
- •Nicotinamide
- •Epigallocatechin gallate
- •Conclusion
- •References
- •Astrocytes in glaucomatous optic neuropathy
- •Introduction
- •Quiescent astrocytes
- •Reactive astrocytes in glaucoma
- •Signal transduction in glaucomatous astrocytes
- •Protein tyrosine kinases (PTKs)
- •Serine/threonine protein mitogen-activated kinases (MAPKs)
- •G protein-coupled receptors
- •Ras superfamily of small G proteins
- •Astrocyte migration in the glaucomatous optic nerve head
- •Cell adhesion of ONH astrocytes
- •Connective tissue changes in the glaucomatous optic nerve head
- •Extracellular matrix synthesis by ONH astrocytes
- •Extracellular matrix degradation by reactive astrocytes
- •Oxidative stress in ONH astrocytes
- •Conclusions
- •Acknowledgments
- •References
- •Glaucoma as a neuropathy amenable to neuroprotection and immune manipulation
- •Glaucoma as a neurodegenerative disease
- •Oxidative stress and free radicals
- •Excessive glutamate, increased calcium levels, and excitotoxicity
- •Deprivation of neurotrophins and growth factors
- •Abnormal accumulation of proteins
- •Pharmacological neuroprotection for glaucoma
- •Protection of the retinal ganglion cells involves the immune system
- •Searching for an antigen for potential glaucoma therapy
- •Concluding remarks
- •References
- •Oxidative stress and glaucoma: injury in the anterior segment of the eye
- •Introduction
- •Oxidative stress
- •Trabecular meshwork
- •IOP increase and free radicals
- •Glaucomatous cascade
- •Nitric oxide and endothelins
- •Extracellular matrix
- •Metalloproteinases
- •Other factors of interest
- •Therapeutic and preventive substances of interest in glaucoma
- •Ginkgo biloba extract
- •Green tea
- •Ginseng
- •Memantine and its derivates
- •Conclusions
- •Abbreviations
- •References
- •Conclusions on neuroprotective treatment targets in glaucoma
- •Acknowledgments
- •References
- •Involvement of the Bcl2 gene family in the signaling and control of retinal ganglion cell death
- •Introduction
- •Intrinsic apoptosis vs. extrinsic apoptosis
- •The Bcl2 family of proteins
- •The requirement of BAX for RGC soma death
- •BH3-only proteins and the early signaling of ganglion cell apoptosis
- •Conclusion
- •Abbreviations
- •Acknowledgments
- •References
- •Assessment of neuroprotection in the retina with DARC
- •Introduction
- •DARC
- •Introducing the DARC technique
- •Annexin 5-labeled apoptosis and ophthalmoloscopy
- •Detection of RGC apoptosis in glaucoma-related animal models with DARC
- •Assessment of glutamate modulation with DARC
- •Glutamate at synaptic endings
- •Glutamate excitotoxicity in glaucoma
- •Assessment of coenzyme Q10 in glaucoma-related models with DARC
- •Summary
- •Abbreviations
- •Acknowledgment
- •References
- •Potential roles of (endo)cannabinoids in the treatment of glaucoma: from intraocular pressure control to neuroprotection
- •Introduction
- •The endocannabinoid system in the eye
- •The IOP-lowering effects of endocannabinoids
- •Endocannabinoids and neuroprotection
- •Conclusions
- •References
- •Glaucoma of the brain: a disease model for the study of transsynaptic neural degeneration
- •Retinal ganglion cells, retino-geniculate neurons
- •Lateral geniculate nucleus
- •Mechanisms of RGC injury in glaucoma
- •Transsynaptic degeneration of the lateral geniculate nucleus in glaucoma
- •Neural degeneration in magno-, parvo-, and koniocellular LGN layers
- •Visual cortex in glaucoma
- •Neuropathology of glaucoma in the visual pathways in the human brain
- •Mechanisms of glaucoma damage in the central visual pathways
- •Implications of central visual system injury in glaucoma
- •Conclusion
- •Acknowledgments
- •References
- •Clinical relevance of optic neuropathy
- •Is there a remodeling of retinal circuitry?
- •Behavioral consequences of glaucoma
- •Glaucoma as a neurodegenerative disease versus neuroplasticity and adaptive changes
- •Future directions
- •Acknowledgment
- •References
- •Targeting excitotoxic/free radical signaling pathways for therapeutic intervention in glaucoma
- •Introduction
- •Channel properties of NMDA receptors correlated with excitotoxicity
- •Downstream signaling cascades after overactivation of NMDA receptors
- •Relevance of excitotoxicity to glaucoma
- •Therapeutic approaches to prevent RGC death by targeting the pathways involved in NMDA excitotoxicity
- •Drugs targeting NMDA receptors
- •Kinetics of NMDA receptor antagonists
- •Memantine
- •NitroMemantines
- •Drugs targeting downstream signaling molecules in NMDA-induced cell death pathways
- •p38 MAPK inhibitors
- •Averting caspase-mediated neurodegeneration
- •Abbreviations
- •Acknowledgments
- •References
- •Stem cells for neuroprotection in glaucoma
- •Introduction
- •Glaucoma as a model of neurodegenerative disease
- •Why use stem cells for neuroprotective therapy?
- •Stem cell sources
- •Neuroprotection by transplanted stem cells
- •Endogenous stem cells
- •Key challenges
- •Conclusion
- •Abbreviations
- •Acknowledgments
- •References
- •The relationship between neurotrophic factors and CaMKII in the death and survival of retinal ganglion cells
- •Introduction
- •Glaucoma and the RGCs
- •Are other retinal cells affected in glaucoma?
- •Retinal ischemia related glaucoma
- •Excitotoxicity and the retina
- •Signal transduction
- •NMDA receptor antagonists and CaMKII
- •Caspase-3 activation in NMDA-induced retinal cell death and its inhibition by m-AIP
- •BDNF and neuroprotection of RGCs
- •Summary and conclusions
- •Abbreviations
- •Acknowledgments
- •References
- •Evidence of the neuroprotective role of citicoline in glaucoma patients
- •Introduction
- •Patients: selection and recruitment criteria
- •Pharmacological treatment protocol
- •Methodology of visual function evaluation: electrophysiological examinations
- •PERG recordings
- •VEP recordings
- •Statistic evaluation of electrophysiological results
- •Electrophysiological (PERG and VEP) responses in OAG patients after the second period of evaluation
- •Effects of citicoline on retinal function in glaucoma patients: neurophysiological implications
- •Effects of citicoline on neural conduction along the visual pathways in glaucoma patients: neurophysiological implications
- •Possibility of neuroprotective role of citicoline in glaucoma patients
- •Conclusive remarks
- •Abbreviations
- •References
- •Neuroprotection: VEGF, IL-6, and clusterin: the dark side of the moon
- •Neuroprotection: VEGF-A, a shared growth factor
- •VEGF-A isoforms
- •VEGF-A receptors
- •Angiogenesis, mitogenesis, and endothelial survival
- •Neurotrophic and neuroprotective effect
- •Intravitreal VEGF inhibition therapy and neuroretina toxicity
- •Neuroprotection: clusterin, a multifunctional protein
- •Clusterin/ApoJ: a debated physiological role
- •Clusterin and diseases
- •Clusterin and the nervous system
- •Neuroprotection: IL-6, VEGF, clusterin, and glaucoma
- •Rational basis for the development of coenzyme Q10 as a neurotherapeutic agent for retinal protection
- •Introduction
- •Ischemia model
- •Neuroprotective effect of Coenzyme Q10 against cell loss yielded by transient ischemia in the RGC layer
- •Retinal ischemia and glutamate
- •Coenzyme Q10 minimizes glutamate increase induced by ischemia/reperfusion
- •Summary
- •Acknowledgment
- •References
- •17beta-Estradiol prevents retinal ganglion cell loss induced by acute rise of intraocular pressure in rat
- •Methods
- •Morphometric analysis
- •Microdialysis
- •Drug application
- •Statistical analysis
- •Results
- •17beta-Estradiol pretreatment minimizes RGC loss
- •Discussion
- •Acknowledgment
sampled by the LDF technique, our data may be considered as reflecting the blood flow changes (elicited by a visual stimulus) in a limited area of the microcirculatory district belonging to the neuro-retinal rim, a key anatomical component of the optic nerve (Jonas and Budde, 2000). Although we cannot speculate about the possible implications of the present data for the pathophysiology of glaucomatous optic neuropathy, the finding of an abnormal flicker-evoked flow regulation in the superficial layers of the optic nerve recorded in both OHT and EOAG eyes clearly merits further investigation.
In conclusion, this LDF study demonstrates a decreased blood flow response to flicker stimulation measured at the neuro-retinal rim of the optic disk in both OHT and EOAG patients. This decrease, which in EOAG is associated with early loss of nerve fiber layer, could be due to a decrease in the activity of the M-cellular pathway in response to flicker. Furthermore, the relation of blood flow changes with visual function data suggests that neural activity and vascular response can be independently altered early in the disease process.
Conclusions and futures directions
Evidence from experimental and clinical studies has been accumulated so far indicating that retinal and optic nerve head microcirculation is modulated by visually evoked neural activity. It has been shown, indeed, that functional hyperemia measured at the neuro-retinal rim of the optic nerve is tightly coupled with retinal activity, mostly generated in inner retinal layers. The human optic nerve may represent an open ‘‘window’’ to the brain where neurovascular and neurometabolic coupling can be noninvasively investigated by optical techniques such as LDF and activity-induced changes in intrinsic optic signals. As recently discussed (Girouard and Iadecola, 2006), the functional hyperemia involves the coordinated interaction of neurons, glia, and vascular cells. Recent evidence in the central nervous system suggests that various vaso-active agents are implicated in functional hyperemia. These have
161
been reviewed in details in a recent paper (Iadecola and Nedergaard, 2007). They include adenosine, nitric oxide, and arachidonic acid metabolites.
OHT and glaucoma may disrupt the neurovascular coupling, indicating that novel clinical protocols aimed at evaluating both visually induced functional hyperemia and activity changes are potentially valuable either for early detection of neuro-ophthalmic disorders or for better understanding of their pathophysiology.
Clearly, much remains to be investigated in this area. The mediators and modulators of the neurovascular and neurometabolic coupling need to be fully elucidated. In normal subjects, the full set of visual stimuli that, being parametrically modulated in their characteristics (i.e. space, time, chromaticity, adaptation state), are able to reveal the neurovascular coupling at the optic nerve needs to be established. Finally, more systematic clinical studies in different ophthalmic disorders will reveal the role of the current proposed approaches in the diagnosis and management of optic nerve diseases.
Acknowledgements
This study was supported by research grant from Fondazione Cassa di Risparmio, in Bologna (to C.E.R. and B.F.) and Fondi di Ateneo, ex 60% (to B.F.).
References
Baker, C.L. and Hess, R.F. (1984) Linear and nonlinear components of human electroretinogram. J. Neurophysiol., 51(5): 952–967.
Baker, C.L., Jr., Hess, R.R., Olsen, B.T. and Zrenner, E. (1988) Current source density analysis of linear and non-linear components of the primate electroretinogram. J. Physiol., 407: 155–176.
Blumenthal, E.Z. and Weinreb, R.N. (2001) Assessment of the retinal nerve fiber layer in clinical trials of glaucoma neuroprotection. Surv. Ophthalmol., 45(Suppl 3): 305–310.
Bonner, R.F. and Nossal, R. (1990) Principles of laser Doppler flowmetry. In: Shepherd A.P. and Oberg P.A. (Eds.), LaserDoppler Blood Flowmetry. Kluwer Academic Publishers, Boston, pp. 57–72.
Buerk, D.G., Riva, C.E. and Cranstoun, S.D. (1995) Frequency and luminance-dependent blood flow and K+ ion changes
162
during flicker stimuli in cat optic nerve head. Invest. Ophthalmol. Vis. Sci., 36: 2216–2227.
Buerk, D.G., Riva, C.E. and Cranstoun, S.D. (1996) Nitric oxide has a vasodilatory role in cat optic nerve head during flicker stimuli. Microvasc. Res., 52: 13–26.
Colotto, A., Salgarello, T., Giudiceandrea, A., De Luca, L.A., Coppe`, A., Buzzonetti, L. and Falsini, B. (1995) Pattern electroretinogram in treated ocular hypertension: a crosssectional study after timolol maleate therapy. Ophthalmic Res., 27: 168–177.
Falsini, B., Colotto, A. and Porciatti, V. (1991) Macular flickerand pattern-ERGs are differently affected in ocular hypertension and glaucoma. Clin. Vision Sci., 6: p. 429.
Falsini, B., Colotto, A., Porciatti, V. and Porrello, G. (1992) Follow-up study with pattern erg in ocular hypertension and glaucoma patients under timolol maleate treatment. Clin. Vision Sci., 7: 341–347.
Falsini, B., Porciatti, V., Fadda, A., Merendino, E., Iarossi, G. and Cermola, S. (1995) The first and second harmonics of the macular flicker electroretinogram: differential effects of retinal diseases. Doc. Ophthalmol., 90: 157–167.
Falsini, B., Riva, C.E. and Logean, E. (2002) Flicker-evoked changes in human optic nerve blood flow: relationship with retinal neural activity. Invest. Ophthalmol. Vis. Sci., 43: 2721–2726.
Fiorentini, A., Porciatti, V., Morrone, M.C. and Burr, D.C. (1996) Visual ageing: unspecific decline of the responses to luminance and colour. Vision Res., 36.
Ghirlanda, G., Di Leo, M.A., Falsini, B., Porciatti, V., Marietti, G. and Greco, A.V. (1991) Detection of inner retina dysfunction by steady-state focal electroretinogram pattern and flicker in early IDDM. Diabetes, 40: 1122–1127.
Girouard, H. and Iadecola, C. (2006) Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease. J. Appl. Physiol., 100: 328–335.
Glovinski, Y., Quigley, H.A. and Dunkelberger, G.R. (1991) Retinal ganglion cells loss is size dependent in experimental glaucoma. Invest. Ophthalmol. Vis. Sci., 32: 484–491.
Gratton, G. and Fabiani, M. (2001) The event-related optical signal: a new tool for studying brain function. Int. J. Psychophysiol., 42: 109–121.
Hafez, A.S., Bizzarro, R.L. and Lesk, M.R. (2003) Evaluation of optic nerve head and peripapillary retinal blood flow in glaucoma patients, ocular hypertension, and normal subjects. Am. J. Ophthalmol., 136: 1022–1031.
Harris, A., Anderson, D.R., Pillunat, L., Joos, K., Knighton, R.W., Kagemann, L. and Martin, B.J. (1996) Laser Doppler flowmetry measurement of changes in human optic nerve head blood flow in response to blood gas perturbations. J. Glaucoma, 5: 258–265.
Hess, R.F. and Baker, C.L. (1984) Human pattern-evoked electroretinogram. J. Neurophysiol., 51(5): 939–951.
Iadecola, C. and Nedergaard, M. (2007) Glial regulation of the cerebral microvasculature. Nat. Neurosci., 10: 1369–1376.
Jonas, J.B. and Budde, W.M. (2000) Diagnosis and pathogenesis of glaucomatous optic neuropathy: morphological aspects. Prog. Retin. Eye Res., 19: 1–40.
Kerrigan-Baumrind, L.A., Quigley, H.A., Pease, M.E., Kerrigan, D.F. and Mitchell, R.S. (2000) Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons. Invest. Ophthalmol. Vis. Sci., 41: 741–748.
Kondo, M., Wang, L. and Bill, A. (1997) The role of nitric oxide in hyperaemic response to flicker in the retina and optic nerve in cats. Acta Ophthalmol. Scand., 75: 232–235.
Korth, M., Nguyen, N.X., Horn, F. and Martus, P. (1994) Scotopic threshold response and scotopic PII in glaucoma. Invest. Ophthalmol. Vis. Sci., 35: 619–625.
Kru¨ger, G., Kastrup, A., Atsushi, T. and Glover, G. (1999) Simultaneous monitoring of dynamic changes in cerebral blood flow and oxygenation during sustained activation of the human visual cortex. Neuroreport, 10: 2939–2943.
Lee, B.B. (1990) Luminance and chromatic modulation sensitivity of macaque ganglion cells and human observers. J. Opt. Soc. Am. A, 7: 2223–2236.
Logean, E., Geiser, M.H. and Riva, C.E. (2005) Laser Doppler instrument to investigate retinal neural activity-induced changes in optic nerve head blood flow. Opt. Lasers Eng., 43: 591–602.
Maffei L. and Fiorentini A. (Eds.), (1986). Generators Sources of the Pattern ERG in Man and Animals. Liss, New York.
Michelson, G., Langhans, M.J. and Groh, M.J.M. (1996) Perfusion of the juxtapapillary retina and the neuroretinal rim area in primary open angle glaucoma. J. Glaucoma, 5: 91–98.
Miller, K.L., Luh, W.M., Liu, T.T., Martinez, A., Obata, T., Wong, E.C., Frank, L.R. and Buxton, R.B. (2001) Nonlinear temporal dynamics of the cerebral blood flow response. Hum. Brain Mapp., 13: 1–12.
Morrone, C., Fiorentini, A. and Bisti, S. (1994a) Patternreversal electroretinogram in response to chromatic stimuli: II. Monkey. Vis. Neurosci., 11: 873–884.
Morrone, C., Porciatti, V., Fiorentini, A. and Burr, D.C. (1994b) Pattern-reversal electroretinogram in response to chromatic stimuli: I. Humans. Vis. Neurosci., 11: 861–871.
Movaffaghy, A., Chamot, S.R., Petrig, B.L. and Riva, C.E. (1998) Blood flow in the human optic nerve head during isometric exercise. Exp. Eye Res., 67: 561–568.
Nicolela, M.T., Hnik, P. and Drance, S.M. (1996) Scanning laser Doppler flowmeter study of retinal and optic disk blood flow in glaucomatous patients. Am. J. Ophthalmol., 122: 775–783.
Petrig, B.L. and Riva, C.E. (1988) Retinal laser-Doppler velocimetry: towards its computer assisted clinical use. Appl. Opt., 27: 1126–1134.
Petrig, B.L., Riva, C.E. and Hayreh, S.S. (1999) Laser Doppler flowmetry and optic nerve head blood flow. Am. J. Ophthalmol., 127: 413–425.
Pfeiffer, N., Tillmon, B. and Bach, M. (1993) Predictive value of the pattern electroretinogram in high-risk ocular hypertension. Invest. Ophthalmol. Vis. Sci., 34: 1710–1715.
Pillunat, L.E., Anderson, D.R., Knighton, R.W., Joos, K.M. and Feuer, W.J. (1997) Autoregulation of human optic nerve head circulation in response to increased intraocular pressure. Exp. Eye Res., 64: 737–744.
Piltz-Seymour, J.R., Grunwald, J.E., Hariprasad, S.M. and Dupont, J. (2001) Optic nerve blood flow is diminished in eyes of primary open-angle glaucoma suspects. Am. J. Ophthalmol., 132: 63–69.
Porciatti, V., di Bartolo, E., Nardi, M.M. and Fiorentini, A. (1997) Responses to chromatic and luminance contrast in glaucoma: a psychophysical and electrophysiological study. Vision Res., 37(14): 1975–1987.
Porciatti, V. and Falsini, B. (1993) Inner retina contribution to the flicker electroretinogram: a comparison with the pattern electroretinogram. Clin. Vision Sci., 8: 435–447.
Porciatti, V., Falsini, B., Brunori, S., Colotto, A. and Morreti, G. (1987) Pattern electroretinogram as a function of spatial frequency in ocular hypertension and early glaucoma. Doc. Ophthalmol., 65: 349–355.
Porciatti, V., Falsini, B., Fadda, A. and Bolzani, R. (1989) Steady-state analysis of the focal ERG to pattern and flicker: relationship between ERG components and retinal pathology. Clin. Vision Sci., 4: 323–332.
Quigley, H.A., Dunkelberger, G.R. and Green, W.R. (1989) Retinal ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma. Am. J. Ophthalmol., 15: 453–464.
Ransom, B.R. and Orkand, R.K. (1996) Glial–neuronal interactions in non-synaptic areas of the brain: studies in the optic nerve. Trends Neurosci., 19: 352–358.
Riva, C.E. and Buerk, D.G. (1998) Dynamic coupling of blood flow to function and metabolism in the optic nerve head. Neuro-ophthalmology, 20: 45–54.
Riva, C.E., Falsini, B. and Logean, E. (2001) Flicker-evoked responses of human optic nerve head blood flow: luminance versus chromatic modulation. Invest. Ophthalmol. Vis. Sci., 42: 756–762.
Riva, C.E., Harino, S., Petrig, B.L. and Shonat, R.D. (1992) Laser Doppler flowmetry in the optic nerve. Exp. Eye Res., 55: 499–506.
Riva, C.E., Harino, S., Shonat, R.D. and Petrig, B.L. (1991) Flicker evoked increase in optic nerve head blood flow in anesthetized cats. Neurosci. Lett., 128: 291–296.
Riva, C.E., Hero, M., Titze´, P. and Petrig, B.L. (1997) Autoregulation of human optic nerve head blood flow in response to acute changes in ocular perfusion pressure. Graefe’s Arch. Clin. Exp. Ophthalmol., 235: 618–626.
Riva, C.E., Logean, E. and Falsini, B. (2004a) Temporal dynamics and magnitude of the blood flow response at the
163
optic disk in normal subjects during functional retinal flickerstimulation. Neurosci. Lett., 356: 75–78.
Riva, C.E., Logean, E. and Falsini, B. (2005) Visually evoked hemodynamical response and assessment of neurovascular coupling in the optic nerve and retina. Prog. Retin. Eye Res., 24: 183–215.
Riva, C.E., Mendel, M.J. and Petrig, B.L. (1995) Flickerinduced optic nerve blood flow change. In: Ocular Blood Flow. New Insights into the Pathogenesis of Ocular Diseases. Karger, Basel, pp. 128–137.
Riva, C.E. and Petrig, B.L. (1997) Laser Doppler flowmetry in the optic nerve head. In: Drance S.M. (Ed.), Vascular Risk Factors and Neuroprotection in Glaucoma — Update 1996. Kugler Publications, Amsterdam/New York, pp 43–55.
Riva, C.E. and Petrig, B.L. (2003) Laser Doppler techniques in ophthamology — principles and applications. In: Fankhauser F. and Kwasniewska S. (Eds.), Lasers in Ophthalmology — Basic, Diagnostic and Surgical Aspects. Kugler Publications, The Hague, The Netherlands, pp. 51–59.
Riva, C.E., Petrig, B.L., Falsini, B. and Logean, E. (2000) Neuro-vascular coupling at the optic nerve head studied by laser Doppler flowmetry. OSA TOPS Vision Sci. Appl., 35: 64–76.
Riva, C.E., Salgarello, T., Logean, E., Colotto, A., Galan, E. and Falsini, B. (2004b) Flicker-evoked response measured at the optic disk rim is reduced in ocular hypertension and early glaucoma. Invest. Ophthalmol. Vis. Sci., 45: 3662–3668.
Roy, C.S. and Sherrington, C.S. (1890) On the regulation of the blood-supply of the brain. J. Physiol., 11: 85–108.
Salgarello, T., Colotto, A., Falsini, B., Buzzonetti, L., Cesari, L., Iarossi, G. and Scullica, L. (1999) Correlation of pattern electroretinogram with optic disc cup shape in ocular hypertension. Invest. Ophthalmol. Vis. Sci., 40: 1989–1997.
Scheiner, A.J., Riva, C.E., Kazahaya, K. and Petrig, B.L. (1994) Effect of flicker on macular blood flow assessed by the blue field simulation technique. Invest. Ophthalmol. Vis. Sci., 35: 3436–3441.
Uchida, H., Brigatti, L. and Caprioli, J. (1996) Detection of structural damage from glaucoma with confocal laser image analysis. Invest. Ophthalmol. Vis. Sci., 37: 2393–2401.
Zonta, M., Angulo, M.C., Gobbo, S., Rosengarten, B., Hossmann, K.A., Pozzan, T. and Carmignoto, G. (2003) Neuron-to-astrocyte signaling is central to the dynamic control of brain microcirculation. Nat. Neurosci., 6: 43–50.